Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option

Atrial fibrillation (AF) is the most common sustained arrhythmia with a prevalence of up to 4% and an upwards trend due to demographic changes. It is associated with an increase in mortality and stroke incidences. While stroke risk can be significantly reduced through anticoagulant therapy, adequate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Pharmacol
Main Authors: Kraft, Manuel, Büscher, Antonius, Wiedmann, Felix, L’hoste, Yannick, Haefeli, Walter E., Frey, Norbert, Katus, Hugo A., Schmidt, Constanze
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8058608/
https://ncbi.nlm.nih.gov/pubmed/33897427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.638445
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados